homehealthcare NewsUSFDA retains official action status of Aarti Drugs' Palghar unit
healthcare | Apr 24, 2018 3:41 PM IST

USFDA retains official action status of Aarti Drugs' Palghar unit

The United States Food and Drug Administration (USFDA) retains official action indicated (OAI) status of Aarti Drugs' Palghar unit, says Adhish Patil, Chief Financial Officer (CFO) of the company.

Recommended Articles

View All

“We had import alert on this unit. We had inspection in second week of December in 2017. There were five observations, three of which we already gave the response in January and for two of them we have asked time till June, 2018,” he said.
“The OIA status means that as of now whatever the status quo was of the facility, it will remain that. So, we still cannot ship any goods to US with this status,” he added.
Patil also said that USFDA will come to inspect the Palghar plant and if satisfied will clear the facility.
Check out our in-depth Market Coverage, Business News & get real-time Stock Market Updates on CNBC-TV18. Also, Watch our channels CNBC-TV18, CNBC Awaaz and CNBC Bajar Live on-the-go!

Top Budget Opinions

    Most Read

    Market Movers

    View All
    Top GainersTop Losers